CN104435252A - Medicine for treating acute mastitis - Google Patents
Medicine for treating acute mastitis Download PDFInfo
- Publication number
- CN104435252A CN104435252A CN201410648077.XA CN201410648077A CN104435252A CN 104435252 A CN104435252 A CN 104435252A CN 201410648077 A CN201410648077 A CN 201410648077A CN 104435252 A CN104435252 A CN 104435252A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- acute mastitis
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Abstract
The invention relates to a medicine for treating acute mastitis. The medicine for treating acute mastitis disclosed by the invention is characterized by comprising the following components in parts by weight: 10-12 parts of paris polyphylla, 10-12 parts of tetrapanax papyriferus, 10-12 parts of honeysuckle, 10-12 parts of fructus forsythiae, 10-12 parts of Indian kalimeris herb, 10-12 parts of dandelion, 10-12 parts of radix bupleuri, 10-12 parts of rheum officinale, 10-12 parts of the root of red-rooted salvia, 10-12 parts of root of common peony, 10-12 parts of immature bitter orange, and 10-12 parts of liquorice. The medicine for treating acute mastitis disclosed by the invention has the advantages of use of easily available raw materials, low cost, obvious treatment effect and the like.
Description
Technical field
The present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicinal formulae.
Background technology
Chinese medicine (Chinese herbology, Traditional Materia Medica), refers to the medicine of application under Han nationality's folk medicine instructs.Chinese medicine is divided into Chinese patent medicine, Chinese crude drug by processing technique.Chinese medicine is originating primarily from China, except plant amedica, animal drugs as Fel Serpentis, Fel Ursi, Agkistrodon, Cornu Cervi Pantotrichum, Cornu Cervi etc.; Shell class as Margarita, Concha Meretricis seu Cyclinae; Mineral substance is as Os Draconis, and Magnetitum etc. are all used to the Chinese medicine of curing the disease.Minority Chinese medicine comes from foreign country, as Radix Panacis Quinquefolii.China working people, for thousands of years in the process combated the disease, by practice, is constantly familiar with, have accumulated abundant medicinal knowledge gradually.Because word in period in romote antiquity is not emerging, these knowledge can only rely on transmission from master to disciple oral instruction, have had word afterwards, and have just recorded gradually, and occurred medical book.These books serve sums up forefathers' experience and is convenient to the effect spreading and promote.Chinese medicine has the history of thousands of years, and be that the very rich experience that Chinese people struggle with disease is for a long time summed up, the prosperity for the Chinese nation has huge contribution.Because medicine medium-height grass class is in the great majority, so the books recording medicine are just called " book on Chinese herbal medicine ".According to textual criticism, when Qin Han, book on Chinese herbal medicine is popular more, but these books on Chinese herbal medicine are lost all unfortunately, can not investigate.The herbal the earliest works now known is called Shennong's Herbal, pandect is totally three volumes, record medicine comprise dynamic, plant, ore deposit three class, totally 365 kinds, every medicine item is downloaded to be had nature and flavor, function and cures mainly, and another example in order describes the basic theories of medication briefly, as toxicity or no toxicity, four natures and five flavors of drug, compatibility law, method of administration and ball, fall apart, the dosage form such as cream, wine, can say it is the summary of China's knowledge of medication before the Chinese, and lay a good foundation for later pharmaceutical development.Greatest works in China's book on Chinese herbal medicine history, achievement extremely brilliant in the history of science of Ye Shi China.Now affecting larger is " Dictionary of Chinese Pharmacy " that nineteen thirty-five Chen Cunren writes.Pandect 2,700,000 word, receive 4300, medicine order, every medicine is introduced name, ancient books another name, basic, the place of production, form, character, composition, usefulness respectively, cured mainly, successive dynasties description textual criticism, discrimination, person of modern times's theory, fit applications, consumption, use compatibility and incompatibility of drugs, reference material etc. 21.Abundant information, comprehensively, summarize relevant discussion at all times, and drawings attached.It is first large-scale dictionary on Traditional Chinese Medicine Phylogeny.Maybe about 7,000 hundred million will be reached to Chinese herbal medicine industry total industrial output value in 2015.
Through general retrieval, do not find the scheme identical with present patent application.
Summary of the invention
The object of the invention is to: propose one and treat acute mastitis medicine.
Treatment acute mastitis medicine of the present invention, it is characterized in that: by weight, by Rhizoma Paridis 10-12 parts, Medulla Tetrapanacis 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Kalimeridis 10-12 parts, Herba Taraxaci 10-12 parts, Radix Bupleuri 10-12 parts, Radix Et Rhizoma Rhei 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Radix Paeoniae Rubra 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition.
Treatment acute mastitis medicine of the present invention, it is characterized in that: by weight, by Rhizoma Paridis 10-12 parts, Medulla Tetrapanacis 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Kalimeridis 10-12 parts, Herba Taraxaci 10-12 parts, Radix Bupleuri 10-12 parts, Radix Et Rhizoma Rhei 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Radix Paeoniae Rubra 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Pulverize, packaging, obtains product.
Packaging: can be every pouch 30g or 500 grams every bag-1000 grams of specifications.
Usage: be decocted in water for oral dose or pour medicated powder 30g into electric cup, the 300ml that adds water boils rear ten minutes, point 3 decoction being taken warmly, every day 1 dose.
Treatment acute mastitis medicine of the present invention, it is characterized in that: by weight, by Rhizoma Paridis 10-12 parts, Medulla Tetrapanacis 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Kalimeridis 10-12 parts, Herba Taraxaci 10-12 parts, Radix Bupleuri 10-12 parts, Radix Et Rhizoma Rhei 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Radix Paeoniae Rubra 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Adopt the method for prior art to extract active ingredient, make powdered granule product.
Treatment acute mastitis medicine of the present invention, it is characterized in that: by weight, by Rhizoma Paridis 10-12 parts, Medulla Tetrapanacis 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Kalimeridis 10-12 parts, Herba Taraxaci 10-12 parts, Radix Bupleuri 10-12 parts, Radix Et Rhizoma Rhei 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Radix Paeoniae Rubra 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Adopt the method for prior art to extract active ingredient and make powdered granule product, and then adopt prior art to make tablet or capsule product.
The present invention has the following advantages and effect: the advantages such as it has raw material and is easy to get, and cost is low, and therapeutic effect is remarkable.
Detailed description of the invention
Below in conjunction with test and clinical trial situation, technical scheme of the present invention is described in further detail.
Treatment acute mastitis medicine of the present invention, it is characterized in that: by weight, by Rhizoma Paridis 10-12 parts, Medulla Tetrapanacis 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Kalimeridis 10-12 parts, Herba Taraxaci 10-12 parts, Radix Bupleuri 10-12 parts, Radix Et Rhizoma Rhei 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Radix Paeoniae Rubra 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Pulverize, packaging, obtains product.
Packaging: can be every pouch 30g or 500 grams every bag-1000 grams of specifications.
Usage: be decocted in water for oral dose or pour medicated powder 30g into electric cup, the 300ml that adds water boils rear ten minutes, point 3 decoction being taken warmly, every day 1 dose.
Chinese medicinal formulae of the present invention is proved recipe handed down from one's ancestors, in the past few decades, has treated many patients, has now enumerated model case as follows:
Model case clinical effectiveness:
Lin, female, 27 years old.Puerperal first quarter moon, left breast swelling pain, fear of cold heating 1 week.Examine and see: left breast redness is scorching hot, interior upper limb can touch 3 cm x 4 centimetres scleroma block, touches a tender spot obviously, and milk is not smooth, and pale complexion, rushes tired weak, uncomfortable in chest, and xerostomia is bitter, light red tongue, yellow fur, thready and rapid pulse.Examine as acute mastitis.Take treatment acute mastitis medicine of the present invention after 1 day, swell and ache and subtract greatly, cold febrile lysis, continue to take treatment acute mastitis medicine of the present invention 3, all disease knowing are removed, and lump in breast disappears.
Liu, female, 23 years old.The 5th day puerperal is heating suddenly, mammary swelling pain.Certain hospital diagnosis is acute mastitis.Intramuscular injection penicillin with 50% Adlerika soak, treat 2 days invalid.Body temperature 38, lays one's hand on the lump that left breast has 21 centimetre x2 centimetre by 17 DEG C, the enlargement of left axillary lymph knot, breast swell and pain.Check: leukocyte 12300, neutrophilic granulocyte 30%.Take treatment acute mastitis medicine of the present invention after 1 day, temperature decline, all diseases alleviate, and continue to take treatment acute mastitis medicine of the present invention 3, and breast swell and pain disappears, and hemogram recovers normal and heals.
Claims (4)
1. a treatment acute mastitis medicine, it is characterized in that: by weight, by Rhizoma Paridis 10-12 parts, Medulla Tetrapanacis 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Kalimeridis 10-12 parts, Herba Taraxaci 10-12 parts, Radix Bupleuri 10-12 parts, Radix Et Rhizoma Rhei 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Radix Paeoniae Rubra 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition.
2. a treatment acute mastitis medicine, it is characterized in that: by weight, by Rhizoma Paridis 10-12 parts, Medulla Tetrapanacis 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Kalimeridis 10-12 parts, Herba Taraxaci 10-12 parts, Radix Bupleuri 10-12 parts, Radix Et Rhizoma Rhei 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Radix Paeoniae Rubra 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Pulverize, packaging, obtains product.
3. a treatment acute mastitis medicine, it is characterized in that: by weight, by Rhizoma Paridis 10-12 parts, Medulla Tetrapanacis 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Kalimeridis 10-12 parts, Herba Taraxaci 10-12 parts, Radix Bupleuri 10-12 parts, Radix Et Rhizoma Rhei 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Radix Paeoniae Rubra 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Adopt the method for prior art to extract active ingredient, make powdered granule product.
4. a treatment acute mastitis medicine, it is characterized in that: by weight, by Rhizoma Paridis 10-12 parts, Medulla Tetrapanacis 10-12 parts, Flos Lonicerae 10-12 parts, Fructus Forsythiae 10-12 parts, Herba Kalimeridis 10-12 parts, Herba Taraxaci 10-12 parts, Radix Bupleuri 10-12 parts, Radix Et Rhizoma Rhei 10-12 parts, Radix Salviae Miltiorrhizae 10-12 parts, Radix Paeoniae Rubra 10-12 parts, Fructus Aurantii Immaturus 10-12 parts, 10-12 parts, Radix Glycyrrhizae composition; Adopt the method for prior art to extract active ingredient and make powdered granule product, and then adopt prior art to make tablet or capsule product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410648077.XA CN104435252A (en) | 2014-11-14 | 2014-11-14 | Medicine for treating acute mastitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410648077.XA CN104435252A (en) | 2014-11-14 | 2014-11-14 | Medicine for treating acute mastitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104435252A true CN104435252A (en) | 2015-03-25 |
Family
ID=52882514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410648077.XA Pending CN104435252A (en) | 2014-11-14 | 2014-11-14 | Medicine for treating acute mastitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104435252A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105343201A (en) * | 2015-11-29 | 2016-02-24 | 韦谷林 | Rheum officinale composition medicine treating acute mastitis |
| CN105412299A (en) * | 2015-11-29 | 2016-03-23 | 韦富林 | Tetrapanax papyriferus combined medicine for treating acute mastitis |
| CN105687598A (en) * | 2016-03-16 | 2016-06-22 | 济南正骐生物科技有限公司 | Traditional Chinese medicine plaster for treating mastitis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526442A (en) * | 2012-03-23 | 2012-07-04 | 代传香 | Medicament for treating mastitis |
| CN103385999A (en) * | 2013-08-01 | 2013-11-13 | 刘建飞 | Chinese medicine composition for treating acute mastitis |
-
2014
- 2014-11-14 CN CN201410648077.XA patent/CN104435252A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526442A (en) * | 2012-03-23 | 2012-07-04 | 代传香 | Medicament for treating mastitis |
| CN103385999A (en) * | 2013-08-01 | 2013-11-13 | 刘建飞 | Chinese medicine composition for treating acute mastitis |
Non-Patent Citations (1)
| Title |
|---|
| 刑桂琴: "急性乳腺炎中医治疗新进展", 《中医药信息》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105343201A (en) * | 2015-11-29 | 2016-02-24 | 韦谷林 | Rheum officinale composition medicine treating acute mastitis |
| CN105412299A (en) * | 2015-11-29 | 2016-03-23 | 韦富林 | Tetrapanax papyriferus combined medicine for treating acute mastitis |
| CN105687598A (en) * | 2016-03-16 | 2016-06-22 | 济南正骐生物科技有限公司 | Traditional Chinese medicine plaster for treating mastitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101380417B (en) | Preparation for quickly treating urticaria | |
| CN103751497A (en) | Medicament for treating mastitis and preparation method thereof | |
| CN104042957A (en) | Traditional Chinese medicine (TCM) composition for treating prostatitis | |
| CN101862424B (en) | Chinese medicinal composition for treating hepatitis B and preparation method thereof | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN104435252A (en) | Medicine for treating acute mastitis | |
| CN104435424A (en) | Medicine for treating male climacteric syndrome | |
| CN103610854A (en) | Traditional Chinese medicine (TCM) for treating allergic rhinitis | |
| CN104383486A (en) | Medicament for treating bronchitis of children | |
| CN102526635A (en) | Medicament for treating premenstrual stress syndrome and preparation method thereof | |
| CN104435567A (en) | Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout | |
| CN104367888A (en) | Medicine for treating acute and chronic balanitis | |
| CN104644857A (en) | Traditional Chinese medicine formula for treating acnes | |
| CN104367949A (en) | Medicament for treating urinary calculus | |
| CN104367951A (en) | Medicine for treating prostate hyperplasia | |
| CN104383485A (en) | Medicine for treating infantile anorexia | |
| CN104383046A (en) | Medicament for treating infantile diarrhea | |
| CN104435313A (en) | Medicine for treating haemorrhoids | |
| CN104367730A (en) | Medicine for treating postpartum urinary retention | |
| CN104056017A (en) | Traditional Chinese medicine composition for treating rheumatism and preparation method thereof | |
| CN104367777A (en) | Medicine for treating spermatorrhea | |
| CN104436029A (en) | Drug for treating pelvic inflammatory disease | |
| CN103830682A (en) | Traditional Chinese medicine composition for treating liver depression and blood stasis syndromes | |
| CN103735829A (en) | Traditional Chinese medicine composition for treating spontaneous perspiration | |
| CN104435350A (en) | Drug for treating functional uterine bleeding |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |